Clinical Trials
11 trialsNCT01042379 2026-05-06
I-SPY
QuantumLeap Healthcare Collaborative
Phase 2 Recruiting
NCT04199026 2026-02-19
Implantable Microdevice for the Delivery of Drugs and Their Effect on Tumors in Patients With Metastatic or Recurrent Sarcoma
M.D. Anderson Cancer Center
Phase NA Recruiting
NCT04129151 2024-08-01
Palbociclib + Ganitumab In Ewing Sarcoma
Dana-Farber Cancer Institute
Phase 2 Terminated
NCT01061788 2019-08-28
RAP
Duke University
Phase 1 Completed
NCT03029481 2019-03-28
Single Patient Expanded Access to Ganitumab for Metastatic Ewing Sarcoma
Jonsson Comprehensive Cancer Center
No longer available
NCT01024387 2018-03-08
AMG 479 in Advanced Carcinoid and Pancreatic Neuroendocrine Tumors
Dana-Farber Cancer Institute
Phase 2 Completed
NCT01122199 2017-05-10
Study of RAD001 + AMG479 for Patients With Advanced Solid Tumors
Indiana University
Phase 1 Completed
NCT01479179 2016-10-26
Trastuzumab in Combination With AMG 479 in HER-2 Overexpressing MBC Progressing on Trastuzumab
M.D. Anderson Cancer Center
Phase 1/2 Withdrawn
NCT01473303 2016-06-28
Combination Chemotherapy With or Without Ganitumab in Treating Patients With Previously Untreated Metastatic Pancreatic Cancer
Alliance for Clinical Trials in Oncology
Phase 1/2 Withdrawn
NCT00718523 2016-01-12
Study of Adding AMG 479 to First Line Chemotherapy in Patients With Optimally Debulked Epithelial Ovarian Cancer
Translational Research in Oncology
Phase 2 Terminated
NCT00719212 2016-01-11
Study of AMG 479 as Second Line Therapy in Patients With Recurrent Platinum-sensitive Ovarian Cancer
Translational Research in Oncology
Phase 2 Completed